Profund Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-32,547
| Closed | -$1.33M | – | 1165 |
|
|
2024
Q2 | $1.33M | Sell |
32,547
-2,687
| -8% | -$110K | 0.05% | 250 |
|
|
2024
Q1 | $1.49M | Buy |
35,234
+11,209
| +47% | +$474K | 0.06% | 230 |
|
|
2023
Q4 | $1.02M | Sell |
24,025
-9,959
| -29% | -$422K | 0.04% | 326 |
|
|
2023
Q3 | $742K | Buy |
33,984
+1,379
| +4% | +$30.1K | 0.04% | 356 |
|
|
2023
Q2 | $1.04M | Sell |
32,605
-6,711
| -17% | -$213K | 0.06% | 309 |
|
|
2023
Q1 | $959K | Buy |
+39,316
| New | +$959K | 0.06% | 311 |
|